samedan logo
 
 
spacer
home > pmps > autumn 2001 > editor's letter
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Editor's Letter

After vacations, during what has probably been the longest and warmest Summer anyone can recall, this Autumn issue of PMPS is a reminder that the trade show season will soon be in full swing, as shown in PMPS' list of forthcoming events. These events are selected for their particular interest to our community of manufacturing professionals. We are particularly keen to hear about events that have a clear focus on contract manufacturing.

As this issue goes to print, Contract Manufacturing and Packaging in Pharmaceuticals organised by Vision in Business is about to take place. It will be quickly followed by the CPhI Worldwide and ICSE (International Contract Services Expo) 2001 event in London on 8th to 10th October, and then an interesting meeting on 10th October in Hanover - BioSupply Europe. Finally, on 16th to 17th October in Brussels, Vision in Business sponsors Biotech

Manufacturing Processes. As you can see, a biomanufacturing theme is reflected in this season's crop, in the run up to 9th Annual BioPartnering Europe in London on 18th to 19th October. We aim to report on some of these important events in the next issue. However, as our editorial team is fully stretched to cover everything that's going on, any feedback from readers would be very welcome. I'm looking forward to meeting you at one of these events.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
PMPS' Editor, Patricia Lobo, unearths an antique crystal ball and gazes into the future of contract manufacturing and packing.
spacer
Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

4th Annual Patient Recruitment and Retention in Clinical Trials

13-15 October 2008, Amsterdam

Patient recruitment is now consuming thirty percent of clinical trial time - more time than any other clinical trial activity - and almost half of all trial delays result from patient recruitment problems. As the recruiting culture becomes more sophisticated and the forces affecting patient enrollment grow more numerous and complex, pharmaceutical companies are striving to discover new strategies to facilitate enrollment in clinical trials. With increasing industry pressure to develop, test and market greater numbers of new drugs faster, pharmaceutical companies need to perform clinical trials as quickly as possible. Inefficient patient recruitment processes is a formidable barrier to pharmaceutical companies' success in launching new products. Improving the patient recruitment process is imperative to avoid wasted investments and eliminate costly delays in bringing new drugs to market -- today and even more so in the not-so-distant future. Improved patient recruitment presents one of the largest opportunities for pharmaceutical companies to eliminate delays in clinical trials, thereby making it possible to reduce time to market.  With patent time limits and large overheads meaning that any delays in the development timeline can be disastrous, a good understanding of how to successfully recruit patients for trials is vital for any company looking to succeed.
More info >>

 
News and Press Releases

Ultra slim and ultra quick


More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement